Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on targeted therapies for life-threatening pulmonary diseases, has appointed Lyn Baranowski as chief executive officer. Ms. Baranowski brings more than two decades of experience leading a vast array of functions in biotech, big pharma and venture capital firms.   Prior to joining Avalyn, Ms. Baranowski served as chief operating officer at Altavant Sciences, a biopharmaceutical company developing therapies for rare respi...